Prevalence and Disease-Specific Risk Factors for Lower Urinary Tract Symptoms in Systemic Sclerosis: An International Multicenter Study-Reference-Cited by-同舟云学术

Prevalence and Disease-Specific Risk Factors for Lower Urinary Tract Symptoms in Systemic Sclerosis: An International Multicenter Study

Published:2018-06-19 Issue:8 Volume:70 Page:1218-1227
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care Res

Author:

John Gregor¹^ORCID,Avouac Jérôme²,Piantoni Silvia³,Polito Pamela⁴,Fredi Micaela³,Cozzi Franco⁴,Airò Paolo³,Truchetet Marie-Elise⁵,Franceschini Franco³,Allanore Yannick²,Chizzolini Carlo⁶

Affiliation:

1. Hôpital Neuchâtelois, La Chaux-de-Fonds, Switzerland, and Geneva University Hospitals; Geneva Switzerland

2. Hôpital Cochin; Paris France

3. ASST Spedali Civili; Brescia Italy

4. University Hospital of Padua; Padua Italy

5. CNRS-UMR 5164 Immuno Concept, Bordeaux University and Bordeaux Hospital; Bordeaux France

6. University Hospital and School of Medicine, University of Geneva; Geneva Switzerland

Publisher

Wiley

Subject

Rheumatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/acr.23454/fullpdf

Reference43 articles.

1. Scleroderma;Gabrielli;N Engl J Med,2009

2. Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies;Avouac;J Rheumatol,2010

3. Mortality in systemic sclerosis: an international meta-analysis of individual patient data;Ioannidis;Am J Med,2005

4. Autoantibodies in systemic sclerosis;Steen;Semin Arthritis Rheum,2005

5. Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?;Mohan;BMJ,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overlooked Manifestations;Scleroderma;2024

2. Do the incidence and severity of lower urinary tract symptoms measured by the international consultation on incontinence questionnaires correlate with urodynamic findings in patients with systemic sclerosis?;Current Urology;2023-06-01

3. Pathogenetic rationale for prescribing menopausal hormone therapy for systemic sclerosis;Rheumatology Science and Practice;2022-11-11

4. Urinary incontinence in systemic sclerosis: a prospective multicentre cohort study;Rheumatology International;2022-08-09

5. Prevalence of moderate to severe lower urinary tract symptoms in systemic sclerosis;Rheumatology;2022-02-02